Q4 EPS Estimate for Patterson Companies Increased by Analyst

Patterson Companies, Inc. (NASDAQ:PDCO) – Equities researchers at Zacks Research raised their Q4 2025 EPS estimates for shares of Patterson Companies in a research note issued to investors on Wednesday, March 19th. Zacks Research analyst I. Bandyopadhyay now forecasts that the company will earn $1.11 per share for the quarter, up from their prior forecast of $0.93. The consensus estimate for Patterson Companies’ current full-year earnings is $2.25 per share. Zacks Research also issued estimates for Patterson Companies’ Q3 2026 earnings at $0.61 EPS, Q3 2027 earnings at $0.60 EPS and FY2027 earnings at $2.44 EPS.

PDCO has been the topic of a number of other reports. Mizuho started coverage on Patterson Companies in a research report on Wednesday, December 4th. They set a “neutral” rating and a $23.00 price target on the stock. Stifel Nicolaus dropped their target price on Patterson Companies from $25.00 to $24.00 and set a “hold” rating on the stock in a research report on Thursday, December 5th. StockNews.com assumed coverage on shares of Patterson Companies in a report on Wednesday, March 19th. They set a “hold” rating for the company. Piper Sandler lowered their price target on shares of Patterson Companies from $26.00 to $24.00 and set a “neutral” rating for the company in a research report on Friday, December 6th. Finally, Leerink Partners reiterated a “market perform” rating and issued a $31.35 price objective (up from $29.00) on shares of Patterson Companies in a research report on Wednesday, December 11th. Eleven equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, Patterson Companies has an average rating of “Hold” and a consensus target price of $26.57.

Patterson Companies Stock Performance

Shares of NASDAQ PDCO opened at $31.20 on Monday. The company has a quick ratio of 0.76, a current ratio of 1.37 and a debt-to-equity ratio of 0.34. The firm’s 50-day moving average price is $31.05 and its two-hundred day moving average price is $26.30. Patterson Companies has a 52-week low of $19.45 and a 52-week high of $31.79. The stock has a market capitalization of $2.76 billion, a P/E ratio of 18.25, a P/E/G ratio of 2.71 and a beta of 0.99.

Hedge Funds Weigh In On Patterson Companies

Large investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its holdings in shares of Patterson Companies by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 9,409,915 shares of the company’s stock valued at $290,390,000 after acquiring an additional 47,897 shares in the last quarter. American Century Companies Inc. lifted its position in Patterson Companies by 24.1% in the fourth quarter. American Century Companies Inc. now owns 2,711,030 shares of the company’s stock worth $83,662,000 after purchasing an additional 527,054 shares during the period. Equity Investment Corp lifted its position in Patterson Companies by 16.6% in the fourth quarter. Equity Investment Corp now owns 2,028,964 shares of the company’s stock worth $62,614,000 after purchasing an additional 289,295 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in Patterson Companies by 15.8% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,799,942 shares of the company’s stock valued at $55,546,000 after purchasing an additional 245,376 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its position in shares of Patterson Companies by 18.0% during the 4th quarter. Bank of New York Mellon Corp now owns 1,455,729 shares of the company’s stock valued at $44,924,000 after purchasing an additional 222,005 shares during the period. Institutional investors and hedge funds own 85.43% of the company’s stock.

About Patterson Companies

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.